Considering the acquired loss-of-function CFTR phenotype of HBE in COPD and chronic bronchitis, understanding the molecular basis of acute and extended CS exposure on CFTR inhibition has important therapeutic implications. Here, CFTR is linked to chronic obstructive pulmonary disease.